GlassScriptPhysician profile
Juan Otheguy
NPI 1992760557
$1,547.30
in general payments reported to CMS, 2019-2025
10 companies · $471 in 2025
The $471 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $31.17 · 2021: $455 · 2022: $324 · 2023: $37.34 · 2024: $45.83 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Education: $14.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.04 |
| Education | $14.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $704.73 | 2021-2025 | Barrigel, Urolift |
| Medtronic, INC. | $253.39 | 2021-2025 | Interstim |
| Coloplast Corp | $202.47 | 2019-2022 | |
| Penumbra, INC. | $137.19 | 2025 | Ruby Coil |
| Astellas Pharma US INC | $135.35 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $38.04 | 2019-2022 | |
| Halozyme INC | $23.23 | 2023 | |
| Urovant Sciences INC | $23.05 | 2022 | |
| Dentsply Ih Ab | $15.74 | 2025 | Lofric |
| Dendreon Pharmaceuticals LLC | $14.11 | 2023 | Provenge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Otheguy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.